A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults
Clinical trial NCT05972174 · COMPLETED
Trial details
- NCT number
- NCT05972174
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-10
- Primary completion
- 2024-07-16
- Enrollment
- 1504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.